|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-7-8
|
|
pubmed:abstractText |
Molecular imaging of human epidermal growth factor receptor type 2 (HER2)-expression in malignant tumors provides potentially important information for patient management. Affibody molecules have shown to be suitable tracers for imaging applications using single photon emission computed tomography or positron emission tomography. Results from an earlier evaluation of the application of site-specific (99m)Tc-labeling of the Affibody molecule, Z(HER2:2395)-C, were favorable.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Cysteine,
http://linkedlifedata.com/resource/pubmed/chemical/Edetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Organotechnetium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Pertechnetate Tc 99m,
http://linkedlifedata.com/resource/pubmed/chemical/Sugar Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Tin Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-glucoheptonic acid,
http://linkedlifedata.com/resource/pubmed/chemical/stannous chloride
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1872-9614
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
539-46
|
|
pubmed:meshHeading |
pubmed-meshheading:20610158-Animals,
pubmed-meshheading:20610158-Antibodies,
pubmed-meshheading:20610158-Cell Line, Tumor,
pubmed-meshheading:20610158-Cysteine,
pubmed-meshheading:20610158-Edetic Acid,
pubmed-meshheading:20610158-Female,
pubmed-meshheading:20610158-Freeze Drying,
pubmed-meshheading:20610158-Humans,
pubmed-meshheading:20610158-Isotope Labeling,
pubmed-meshheading:20610158-Mice,
pubmed-meshheading:20610158-Organotechnetium Compounds,
pubmed-meshheading:20610158-Protein Engineering,
pubmed-meshheading:20610158-Receptor, erbB-2,
pubmed-meshheading:20610158-Recombinant Proteins,
pubmed-meshheading:20610158-Reproducibility of Results,
pubmed-meshheading:20610158-Sodium Pertechnetate Tc 99m,
pubmed-meshheading:20610158-Sugar Acids,
pubmed-meshheading:20610158-Time Factors,
pubmed-meshheading:20610158-Tin Compounds
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine.
|
|
pubmed:affiliation |
Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, SE-751 85, Uppsala, Sweden. sara.ahlgren@medsci.uu.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
